Management of myocarditis

Chantal El Amm, Leslie T Jr. Cooper

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Myocarditis refers to inflammation of the myocardium, which can result in chest pain, arrhythmias and dilated cardiomyopathy. The presenting symptoms are non specific and diverse triggers, most commonly viruses, can lead to the common clinical presentations. The pathogenesis of myocarditis can be simplified into a phase of acute injury resulting in an innate and adaptive immunological response, which downregulates in most patients leading to myocardial recovery. In a minority of cases, extensive scar form the initial injury or persistent inflammation results in chronic dilated cardiomyopathy. Cardiac magnetic resonance imaging is used in the diagnosis, with endomyocardial biopsy being reserved for cases in which the result will significantly alter prognosis or therapy. The management of myocarditis in patients with cardiomyopathy depends on the presence of infection and inflammation; if there is no evidence of either then patients are treated with standard guideline-based heart failure therapy. Emerging therapeutic strategies focus on modulating patient-specific immune reactions. Patients who fail to respond to medical therapy and have advanced heart failure may require mechanical circulatory support or heart transplantation.

Original languageEnglish (US)
Pages (from-to)8-12
Number of pages5
JournalHeart and Metabolism
Issue number62
StatePublished - 2014

Fingerprint

Myocarditis
Dilated Cardiomyopathy
Inflammation
Heart Failure
Wounds and Injuries
Heart Transplantation
Therapeutics
Chest Pain
Cardiomyopathies
Cicatrix
Cardiac Arrhythmias
Myocardium
Down-Regulation
Magnetic Resonance Imaging
Guidelines
Viruses
Biopsy
Infection

Keywords

  • Endomyocardial biopsy
  • Heart failure
  • Myocarditis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Management of myocarditis. / El Amm, Chantal; Cooper, Leslie T Jr.

In: Heart and Metabolism, No. 62, 2014, p. 8-12.

Research output: Contribution to journalArticle

El Amm, Chantal ; Cooper, Leslie T Jr. / Management of myocarditis. In: Heart and Metabolism. 2014 ; No. 62. pp. 8-12.
@article{cdaa2938f3fc4823a94320101801f828,
title = "Management of myocarditis",
abstract = "Myocarditis refers to inflammation of the myocardium, which can result in chest pain, arrhythmias and dilated cardiomyopathy. The presenting symptoms are non specific and diverse triggers, most commonly viruses, can lead to the common clinical presentations. The pathogenesis of myocarditis can be simplified into a phase of acute injury resulting in an innate and adaptive immunological response, which downregulates in most patients leading to myocardial recovery. In a minority of cases, extensive scar form the initial injury or persistent inflammation results in chronic dilated cardiomyopathy. Cardiac magnetic resonance imaging is used in the diagnosis, with endomyocardial biopsy being reserved for cases in which the result will significantly alter prognosis or therapy. The management of myocarditis in patients with cardiomyopathy depends on the presence of infection and inflammation; if there is no evidence of either then patients are treated with standard guideline-based heart failure therapy. Emerging therapeutic strategies focus on modulating patient-specific immune reactions. Patients who fail to respond to medical therapy and have advanced heart failure may require mechanical circulatory support or heart transplantation.",
keywords = "Endomyocardial biopsy, Heart failure, Myocarditis",
author = "{El Amm}, Chantal and Cooper, {Leslie T Jr.}",
year = "2014",
language = "English (US)",
pages = "8--12",
journal = "Heart and Metabolism",
issn = "1566-0338",
publisher = "Imprimerie Jouve",
number = "62",

}

TY - JOUR

T1 - Management of myocarditis

AU - El Amm, Chantal

AU - Cooper, Leslie T Jr.

PY - 2014

Y1 - 2014

N2 - Myocarditis refers to inflammation of the myocardium, which can result in chest pain, arrhythmias and dilated cardiomyopathy. The presenting symptoms are non specific and diverse triggers, most commonly viruses, can lead to the common clinical presentations. The pathogenesis of myocarditis can be simplified into a phase of acute injury resulting in an innate and adaptive immunological response, which downregulates in most patients leading to myocardial recovery. In a minority of cases, extensive scar form the initial injury or persistent inflammation results in chronic dilated cardiomyopathy. Cardiac magnetic resonance imaging is used in the diagnosis, with endomyocardial biopsy being reserved for cases in which the result will significantly alter prognosis or therapy. The management of myocarditis in patients with cardiomyopathy depends on the presence of infection and inflammation; if there is no evidence of either then patients are treated with standard guideline-based heart failure therapy. Emerging therapeutic strategies focus on modulating patient-specific immune reactions. Patients who fail to respond to medical therapy and have advanced heart failure may require mechanical circulatory support or heart transplantation.

AB - Myocarditis refers to inflammation of the myocardium, which can result in chest pain, arrhythmias and dilated cardiomyopathy. The presenting symptoms are non specific and diverse triggers, most commonly viruses, can lead to the common clinical presentations. The pathogenesis of myocarditis can be simplified into a phase of acute injury resulting in an innate and adaptive immunological response, which downregulates in most patients leading to myocardial recovery. In a minority of cases, extensive scar form the initial injury or persistent inflammation results in chronic dilated cardiomyopathy. Cardiac magnetic resonance imaging is used in the diagnosis, with endomyocardial biopsy being reserved for cases in which the result will significantly alter prognosis or therapy. The management of myocarditis in patients with cardiomyopathy depends on the presence of infection and inflammation; if there is no evidence of either then patients are treated with standard guideline-based heart failure therapy. Emerging therapeutic strategies focus on modulating patient-specific immune reactions. Patients who fail to respond to medical therapy and have advanced heart failure may require mechanical circulatory support or heart transplantation.

KW - Endomyocardial biopsy

KW - Heart failure

KW - Myocarditis

UR - http://www.scopus.com/inward/record.url?scp=84899580541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899580541&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84899580541

SP - 8

EP - 12

JO - Heart and Metabolism

JF - Heart and Metabolism

SN - 1566-0338

IS - 62

ER -